L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.
Elizan
T S
TS
Department of Neurology, Mt. Sinai Medical Center, City University of New York, New York.
Yahr
M D
MD
Moros
D A
DA
Mendoza
M R
MR
Pang
S
S
Bodian
C A
CA
D000368:Aged; D002230:Carbidopa / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D011446:Prospective Studies; D012642:Selegiline / Q000008:administration & dosage*
D012642:Selegiline; D007980:Levodopa; D002230:Carbidopa